HCSG
Healthcare Services Group Inc
Healthcare Services Group Inc historical holders
total: 2
Giverny Capital Healthcare Services Group Inc transactions over time
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 3
- Held since:
- 2018 Q3
- Held for:
- 13 quarters
- Latest activity:
- 2021 Q4
Francois Rochon has been an institutional investor in Healthcare Services Group Inc (HCSG) since 2018 Q3. According to 2026 Q1 report, Francois Rochon doesn't hold any shares. The fund/company first acquired HCSG in 2018 Q3, initially purchasing 9,266 shares. Since the initial investment, Giverny Capital has made 12 more transactions in this position.
When did Francois Rochon exit their HCSG position?
Francois Rochon no longer holds Healthcare Services Group Inc (HCSG). They sold off their entire position in 2021 Q4, closing out an investment that began in 2018 Q3.
When did Francois Rochon first invest in HCSG?
Francois Rochon first invested in Healthcare Services Group Inc (HCSG) in 2018 Q3 at the reported quarter-end price of $40.58 per share, acquiring 9,266 shares in their initial purchase.
What is Francois Rochon's average cost basis for HCSG?
Based on historical transaction data, Francois Rochon's estimated cost basis for Healthcare Services Group Inc (HCSG) is approximately $31.37 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $31.37
- Weighted AVG sell price:
- $24.90
HCSG transactions history by Giverny Capital
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$24.99
|
|
-100% (-370,166)
|
-0.55%
|
|
2021 Q3
|
0.55%
|
370,166
|
$24.99
|
$9,250,000
|
-0.05% (-179)
|
-0%
|
|
2021 Q2
|
0.71%
|
370,345
|
$31.57
|
$11,692,000
|
+1.66% (+6,033)
|
+0.01%
|
|
2021 Q1
|
0.68%
|
364,312
|
$28.03
|
$10,212,000
|
+0.68% (+2,463)
|
+0%
|
|
2020 Q4
|
0.78%
|
$28.10
|
+1.45% (+5,156)
|
|||
|
2020 Q3
|
0.70%
|
$21.53
|
-0.55% (-1,955)
|
|||
|
2020 Q2
|
0.87%
|
$24.46
|
+21.73% (+64,022)
|
|||
|
2020 Q1
|
0.90%
|
$23.91
|
-7.85% (-25,084)
|
|||
|
2019 Q4
|
0.70%
|
$24.32
|
+1.20% (+3,802)
|
|||
|
2019 Q3
|
0.76%
|
$24.29
|
+0.71% (+2,230)
|
|||
|
2019 Q2
|
0.96%
|
$30.32
|
+9.17% (+26,344)
|
|||
|
2019 Q1
|
1.09%
|
$32.99
|
+3,000.95% (+278,068)
|
|||
|
2018 Q3
|
0.04%
|
$40.58
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.